|
|
Article: Research and Markets: Gene Therapy - Technologies, Markets and Companies: New Products Expected to be approved by 2005.
- Article from:
- Business Wire
- Article date:
- April 28, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors
DUBLIN, Ireland--(BUSINESS WIRE)--April 28, 2004
Research and Markets (http://www.researchandmarkets.com) has announced the addition of Gene Therapy - Technologies, Markets and Companies to their offering.
Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes and DNA are now being introduced without the use of vectors and various techniques are being used to modify the function of genes in vivo without gene transfer. If one adds to this the cell therapy particularly with use of ...